Redhawk Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$992K Buy
17,209
+13,108
+320% +$753K 0.1% 183
2026
Q1
$249K Buy
+4,101
New +$239K 0.03% 336
2024
Q2
Sell
-6,976
Closed -$378K 302
2024
Q1
$378K Buy
+6,976
New +$355K 0.06% 221
2023
Q4
Sell
-11,935
Closed -$693K 290
2023
Q3
$693K Sell
11,935
-68
-0.6% -$4.17K 0.23% 96
2023
Q2
$768K Sell
12,003
-7,237
-38% -$485K 0.23% 92
2023
Q1
$1.33M Buy
19,240
+3,545
+23% +$250K 0.45% 55
2022
Q4
$1.13M Buy
15,695
+639
+4% +$48.2K 0.44% 66
2022
Q3
$1.07M Buy
15,056
+3,603
+31% +$261K 0.45% 59
2022
Q2
$882K Buy
+11,453
New +$872K 0.4% 66
2021
Q2
Sell
-8,306
Closed -$524K 262
2021
Q1
$524K Sell
8,306
-1,406
-14% -$87.5K 0.13% 129
2020
Q4
$602K Sell
9,712
-2,767
-22% -$170K 0.15% 114
2020
Q3
$752K Buy
12,479
+1,316
+12% +$79.2K 0.22% 88
2020
Q2
$656K Sell
11,163
-2,881
-21% -$172K 0.23% 73
2020
Q1
$783K Buy
14,044
+4,222
+43% +$258K 0.35% 54
2019
Q4
$630K Buy
+9,822
New +$563K 0.24% 63
2019
Q3
Sell
-1,475
Closed -$67K 167
2019
Q2
$67K Buy
+1,475
New +$68.7K 0.03% 226

Other funds holding BMY

Redhawk Wealth Advisors's BMY Position: Q2 2026 in Review

Redhawk Wealth Advisors increased its Bristol-Myers Squibb (BMY) stake by 320% in Q2 2026, buying an estimated $753K and bringing the position to 17,209 shares worth $992K. The position accounts for 0.1% of the portfolio, ranked #183.

Redhawk Wealth Advisors first reported a position in BMY in Q2 2019 and has held it in 16 quarters since. The position peaked at $1.33M in Q1 2023. 500 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Redhawk Wealth Advisors held 17,209 shares of Bristol-Myers Squibb worth $992K as of Q2 2026.
  • Redhawk Wealth Advisors bought 13,108 Bristol-Myers Squibb shares in Q2 2026, an estimated $753K.
  • Bristol-Myers Squibb made up 0.1% of Redhawk Wealth Advisors's portfolio in Q2 2026, its #183 holding.
  • Redhawk Wealth Advisors first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 16 quarters since.
  • Redhawk Wealth Advisors's Bristol-Myers Squibb position peaked at $1.33M in Q1 2023.
  • 500 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.